Hyperkalaemia is a common and potentially life threatening electrolyte abnormality.
This state of the art review summarises data on the epidemiology, identifies key risk factors and diagnostic considerations, and reviews approaches to management
https://bit.ly/4ztlTN0
This state of the art review summarises data on the epidemiology, identifies key risk factors and diagnostic considerations, and reviews approaches to management
https://bit.ly/4ztlTN0
August 23, 2026 at 4:28 PM
Hyperkalaemia is a common and potentially life threatening electrolyte abnormality.
This state of the art review summarises data on the epidemiology, identifies key risk factors and diagnostic considerations, and reviews approaches to management
https://bit.ly/4ztlTN0
This state of the art review summarises data on the epidemiology, identifies key risk factors and diagnostic considerations, and reviews approaches to management
https://bit.ly/4ztlTN0
Excited to share our new paper in BMC Nephrology examining hyperkalaemia in hospital patients. Proud of working with @andrewmallett8.bsky.social and the team in advancing understanding of this important condition.
Link to paper: doi.org/10.1186/s128...
Link to paper: doi.org/10.1186/s128...
Hyperkalaemia among hospital admissions: prevalence, risk factors, treatment and impact on length of stay - BMC Nephrology
Background Hyperkalaemia is one of the common electrolyte disorders among hospital patients, affected by many risk factors including medications and medical conditions. Prompt treatment is important g...
doi.org
December 18, 2024 at 10:48 PM
Excited to share our new paper in BMC Nephrology examining hyperkalaemia in hospital patients. Proud of working with @andrewmallett8.bsky.social and the team in advancing understanding of this important condition.
Link to paper: doi.org/10.1186/s128...
Link to paper: doi.org/10.1186/s128...
Applying the ‘touch-and-go’ concept to #MRAs : A paradigm shift in routine heart failure management
Addressing the barriers: rethinking WRF and #hyperkalaemia
onlinelibrary.wiley.com/doi/abs/10.1... @escardio.bsky.social @anastasiasmihaili.bsky.social @shelleyzieroth.bsky.social
Addressing the barriers: rethinking WRF and #hyperkalaemia
onlinelibrary.wiley.com/doi/abs/10.1... @escardio.bsky.social @anastasiasmihaili.bsky.social @shelleyzieroth.bsky.social
December 27, 2024 at 10:18 PM
Applying the ‘touch-and-go’ concept to #MRAs : A paradigm shift in routine heart failure management
Addressing the barriers: rethinking WRF and #hyperkalaemia
onlinelibrary.wiley.com/doi/abs/10.1... @escardio.bsky.social @anastasiasmihaili.bsky.social @shelleyzieroth.bsky.social
Addressing the barriers: rethinking WRF and #hyperkalaemia
onlinelibrary.wiley.com/doi/abs/10.1... @escardio.bsky.social @anastasiasmihaili.bsky.social @shelleyzieroth.bsky.social
In real life, recognizing pseudo-hyperkalemia risk is key! Home sampling, transport delays, and temperature impact results. 🚨 --> academic.oup.com/ndt/article/...
Pseudo-hyperkalaemia in ambulatory samples: the never-ending story?
Hyperkalaemia is a major electrolyte disturbance, which can be life-threatening [1, 2]. Pseudo-hyperkalaemia has been described since 1955 but remains a fr
academic.oup.com
March 19, 2025 at 10:27 AM
In real life, recognizing pseudo-hyperkalemia risk is key! Home sampling, transport delays, and temperature impact results. 🚨 --> academic.oup.com/ndt/article/...
academic.oup.com/ckj/advance-...
Thanks to my fabulous team in Glasgow for their help with this one 🏴
Thanks to my fabulous team in Glasgow for their help with this one 🏴
Sodium zirconium cyclosilicate treatment and rates of emergency interventions for hyperkalaemia: a propensity–score weighted case–control study
ABSTRACTBackground. Sodium zirconium cyclosilicate (SZC) reduces serum potassium in patients with chronic hyperkalaemia in clinical trials, but its role in
academic.oup.com
November 18, 2024 at 9:26 AM
academic.oup.com/ckj/advance-...
Thanks to my fabulous team in Glasgow for their help with this one 🏴
Thanks to my fabulous team in Glasgow for their help with this one 🏴
The World Health Organization now recommends replacing regular table salt with potassium enriched salt to reduce blood pressure and cardiovascular risk.
However, people with chronic kidney disease [CKD] are excluded from the recommendation due to concerns about hyperkalaemia.
[1/2]
However, people with chronic kidney disease [CKD] are excluded from the recommendation due to concerns about hyperkalaemia.
[1/2]
August 27, 2025 at 7:07 AM
The World Health Organization now recommends replacing regular table salt with potassium enriched salt to reduce blood pressure and cardiovascular risk.
However, people with chronic kidney disease [CKD] are excluded from the recommendation due to concerns about hyperkalaemia.
[1/2]
However, people with chronic kidney disease [CKD] are excluded from the recommendation due to concerns about hyperkalaemia.
[1/2]
Thanks! 🙏 Our Clinical Practice Guidelines Committee is always hard at work - AND we're currently updating our interactive guidelines website to include 3 more UK guidelines! (hyperkalaemia, anaemia & haemodialysis) guidelines.ukkidney.org
November 22, 2024 at 5:49 PM
Thanks! 🙏 Our Clinical Practice Guidelines Committee is always hard at work - AND we're currently updating our interactive guidelines website to include 3 more UK guidelines! (hyperkalaemia, anaemia & haemodialysis) guidelines.ukkidney.org
PseudoHypoAldosteronism IID
#CaseReport
9 y/o♂️
Hyperkalaemia
Metabolic acidosis
No hypertension
Low-dose hydrochlorothiazide/2 d
KLHL3 homoz splice-site mut c.135-2A>G
Inactive KLHL3-CUL3 E3 ligase stabilizes WNK1/4➡️⏫renal Sodium-Chloride Cotransporter
onlinelibrary.wiley.com/doi/10.1111/...
#CaseReport
9 y/o♂️
Hyperkalaemia
Metabolic acidosis
No hypertension
Low-dose hydrochlorothiazide/2 d
KLHL3 homoz splice-site mut c.135-2A>G
Inactive KLHL3-CUL3 E3 ligase stabilizes WNK1/4➡️⏫renal Sodium-Chloride Cotransporter
onlinelibrary.wiley.com/doi/10.1111/...
May 1, 2026 at 7:24 PM
PseudoHypoAldosteronism IID
#CaseReport
9 y/o♂️
Hyperkalaemia
Metabolic acidosis
No hypertension
Low-dose hydrochlorothiazide/2 d
KLHL3 homoz splice-site mut c.135-2A>G
Inactive KLHL3-CUL3 E3 ligase stabilizes WNK1/4➡️⏫renal Sodium-Chloride Cotransporter
onlinelibrary.wiley.com/doi/10.1111/...
#CaseReport
9 y/o♂️
Hyperkalaemia
Metabolic acidosis
No hypertension
Low-dose hydrochlorothiazide/2 d
KLHL3 homoz splice-site mut c.135-2A>G
Inactive KLHL3-CUL3 E3 ligase stabilizes WNK1/4➡️⏫renal Sodium-Chloride Cotransporter
onlinelibrary.wiley.com/doi/10.1111/...
Season#14 of the Skeptics' Guide to Emergency Medicine starts tomorrow with this SRMA on hyperkalemia.
www.resuscitationjournal.com/article/S030...
www.resuscitationjournal.com/article/S030...
Pharmacological interventions for the acute treatment of hyperkalaemia: A systematic review and meta-analysis
Hyperkalaemia is a life-threatening electrolyte disturbance and also a potential cause
of cardiac arrest. The objective was to assess the effects of acute pharmacological
interventions for the treatme...
www.resuscitationjournal.com
September 5, 2025 at 11:39 AM
Season#14 of the Skeptics' Guide to Emergency Medicine starts tomorrow with this SRMA on hyperkalemia.
www.resuscitationjournal.com/article/S030...
www.resuscitationjournal.com/article/S030...
Treatment of acute hyperkalaemia in adults
tilpharmacist.substack.com/p/treatment-...
tilpharmacist.substack.com/p/treatment-...
Treatment of acute hyperkalaemia in adults
Hyperkalaemia is a medical condition in which the potassium level in the blood is raised.
tilpharmacist.substack.com
August 30, 2026 at 10:45 AM
Treatment of acute hyperkalaemia in adults
tilpharmacist.substack.com/p/treatment-...
tilpharmacist.substack.com/p/treatment-...
That's REALLY interesting. I'd actually believe that over adrenaline being The Signal
Hyperkalemia too, apparently: www.ovid.com/journals/bmj...
Hyperkalemia too, apparently: www.ovid.com/journals/bmj...
The first symptom of hyperkalaemia is death: IN... : Evidence Based Medicine
Abstract was not provided for this article.
www.ovid.com
August 25, 2025 at 10:08 PM
That's REALLY interesting. I'd actually believe that over adrenaline being The Signal
Hyperkalemia too, apparently: www.ovid.com/journals/bmj...
Hyperkalemia too, apparently: www.ovid.com/journals/bmj...
The lines in ‘higher’ eGFR flozin RCTs (this one is DAPA-CKD) cross at 12-18 months, so if eGFR <20 but you think you’ve got longer than that until ESKD (lots of patients!) then #flozinate to slow CKD.
Side-effects may include preventing AKI, hyperkalaemia, CCF & death in a high risk group.
Side-effects may include preventing AKI, hyperkalaemia, CCF & death in a high risk group.
November 22, 2024 at 4:46 PM
The lines in ‘higher’ eGFR flozin RCTs (this one is DAPA-CKD) cross at 12-18 months, so if eGFR <20 but you think you’ve got longer than that until ESKD (lots of patients!) then #flozinate to slow CKD.
Side-effects may include preventing AKI, hyperkalaemia, CCF & death in a high risk group.
Side-effects may include preventing AKI, hyperkalaemia, CCF & death in a high risk group.
Agree, excellent #NephMadness region.
I am still looking for the holy grail: a treatment* for rHTN in haemodialysis patients that controls HTN, smoothes the BP rollercoaster, and doesn't give hyperkalaemia.
* Other than daily HHD and bilateral nephrectomies
I am still looking for the holy grail: a treatment* for rHTN in haemodialysis patients that controls HTN, smoothes the BP rollercoaster, and doesn't give hyperkalaemia.
* Other than daily HHD and bilateral nephrectomies
a painting of a cup in the clouds
ALT: a painting of a cup in the clouds
media.tenor.com
March 4, 2025 at 12:42 AM
Agree, excellent #NephMadness region.
I am still looking for the holy grail: a treatment* for rHTN in haemodialysis patients that controls HTN, smoothes the BP rollercoaster, and doesn't give hyperkalaemia.
* Other than daily HHD and bilateral nephrectomies
I am still looking for the holy grail: a treatment* for rHTN in haemodialysis patients that controls HTN, smoothes the BP rollercoaster, and doesn't give hyperkalaemia.
* Other than daily HHD and bilateral nephrectomies
📚
Floege, J., Frankel, A. H., Erickson, K. F., Rtveladze, K., Punekar, Y., Mir, J. N., Walters, J., Ehm, A., & Fotheringham, J. (2025). The burden of hyperkalaemia in chronic kidney disease: A systematic literature review. Clinical Kidney Journal, 18(5), sfaf127
academic.oup.com/ckj/article/...
Floege, J., Frankel, A. H., Erickson, K. F., Rtveladze, K., Punekar, Y., Mir, J. N., Walters, J., Ehm, A., & Fotheringham, J. (2025). The burden of hyperkalaemia in chronic kidney disease: A systematic literature review. Clinical Kidney Journal, 18(5), sfaf127
academic.oup.com/ckj/article/...
October 10, 2025 at 9:44 PM
📚
Floege, J., Frankel, A. H., Erickson, K. F., Rtveladze, K., Punekar, Y., Mir, J. N., Walters, J., Ehm, A., & Fotheringham, J. (2025). The burden of hyperkalaemia in chronic kidney disease: A systematic literature review. Clinical Kidney Journal, 18(5), sfaf127
academic.oup.com/ckj/article/...
Floege, J., Frankel, A. H., Erickson, K. F., Rtveladze, K., Punekar, Y., Mir, J. N., Walters, J., Ehm, A., & Fotheringham, J. (2025). The burden of hyperkalaemia in chronic kidney disease: A systematic literature review. Clinical Kidney Journal, 18(5), sfaf127
academic.oup.com/ckj/article/...
Diagnosis and management of acute hyperkalaemia
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
August 23, 2026 at 6:07 PM
Diagnosis and management of acute hyperkalaemia
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
Discovered a new vocal stim while studying: singing 'hyperkalaemia' to the tune of the Taz of Tasmania theme song
February 6, 2026 at 7:17 AM
Discovered a new vocal stim while studying: singing 'hyperkalaemia' to the tune of the Taz of Tasmania theme song
Our State of the Art review entitled Diagnosis and Management of Acute Hyperkalaemia published @bmj.com 👇
✅Check it out for a nice overview of the epidemiology and pathophysiology of hyperkalaemia, key risk factors and diagnostic considerations, and evidence based approaches to acute management
✅Check it out for a nice overview of the epidemiology and pathophysiology of hyperkalaemia, key risk factors and diagnostic considerations, and evidence based approaches to acute management
Hyperkalaemia is a common and potentially life threatening electrolyte abnormality.
This state of the art review summarises data on the epidemiology, identifies key risk factors and diagnostic considerations, and reviews approaches to management
https://bit.ly/4ztlTN0
This state of the art review summarises data on the epidemiology, identifies key risk factors and diagnostic considerations, and reviews approaches to management
https://bit.ly/4ztlTN0
August 24, 2026 at 9:23 PM
Our State of the Art review entitled Diagnosis and Management of Acute Hyperkalaemia published @bmj.com 👇
✅Check it out for a nice overview of the epidemiology and pathophysiology of hyperkalaemia, key risk factors and diagnostic considerations, and evidence based approaches to acute management
✅Check it out for a nice overview of the epidemiology and pathophysiology of hyperkalaemia, key risk factors and diagnostic considerations, and evidence based approaches to acute management
Pharmacological interventions for the acute treatment of hyperkalaemia: A systematic review and meta-analysis - Resuscitation www.resuscitationjournal.com/article/S030...
Pharmacological interventions for the acute treatment of hyperkalaemia: A systematic review and meta-analysis
Hyperkalaemia is a life-threatening electrolyte disturbance and also a potential cause
of cardiac arrest. The objective was to assess the effects of acute pharmacological
interventions for the treatme...
www.resuscitationjournal.com
January 31, 2025 at 5:53 AM
Pharmacological interventions for the acute treatment of hyperkalaemia: A systematic review and meta-analysis - Resuscitation www.resuscitationjournal.com/article/S030...
Ab jetzt online - die Leitlinie "Treatment of Acute Hyperkalaemia in Adults" der UK Kidney Association (UKKA): foamio.org/leitlinie-tr...
#foamio #foam #rettungsdienst #notfallmedizin #Hyperkaliämie #Reanimation #Dialyse
#foamio #foam #rettungsdienst #notfallmedizin #Hyperkaliämie #Reanimation #Dialyse
Leitlinie „Treatment of Acute Hyperkalaemia in Adults“ der UKKA – FOAMio
foamio.org
January 18, 2024 at 6:55 PM
Ab jetzt online - die Leitlinie "Treatment of Acute Hyperkalaemia in Adults" der UK Kidney Association (UKKA): foamio.org/leitlinie-tr...
#foamio #foam #rettungsdienst #notfallmedizin #Hyperkaliämie #Reanimation #Dialyse
#foamio #foam #rettungsdienst #notfallmedizin #Hyperkaliämie #Reanimation #Dialyse
Could potassium be used as an independent predictor of 30-day survival in OHCA?
sjtrem.biomedcentral.com/articles/10....
#OHCA #prehospital #hyperkalaemia #hypokalaemia #ALS
sjtrem.biomedcentral.com/articles/10....
#OHCA #prehospital #hyperkalaemia #hypokalaemia #ALS
October 2, 2025 at 11:50 AM
Could potassium be used as an independent predictor of 30-day survival in OHCA?
sjtrem.biomedcentral.com/articles/10....
#OHCA #prehospital #hyperkalaemia #hypokalaemia #ALS
sjtrem.biomedcentral.com/articles/10....
#OHCA #prehospital #hyperkalaemia #hypokalaemia #ALS
Ok. I’ll play. The adverse kidney outcomes are higher in the intensive treatment group, as are the incidence of hyperkalaemia and hypotension.
What would be your estimate of the number of antihypertensive drugs required per person to get to target sBP of 120?
Number of additional consults?
What would be your estimate of the number of antihypertensive drugs required per person to get to target sBP of 120?
Number of additional consults?
November 17, 2024 at 2:57 AM
Ok. I’ll play. The adverse kidney outcomes are higher in the intensive treatment group, as are the incidence of hyperkalaemia and hypotension.
What would be your estimate of the number of antihypertensive drugs required per person to get to target sBP of 120?
Number of additional consults?
What would be your estimate of the number of antihypertensive drugs required per person to get to target sBP of 120?
Number of additional consults?
New article to read! Potassium binders and continuation of renin–angiotensin system inhibitors/mineralocorticoid receptor antagonist in chronic kidney disease and heart failure.
🔗 doi.org/10.1111/joim.70087
#CKD #Hyperkalaemia #heartfailure #RAASi
🔗 doi.org/10.1111/joim.70087
#CKD #Hyperkalaemia #heartfailure #RAASi
March 26, 2026 at 2:30 PM
New article to read! Potassium binders and continuation of renin–angiotensin system inhibitors/mineralocorticoid receptor antagonist in chronic kidney disease and heart failure.
🔗 doi.org/10.1111/joim.70087
#CKD #Hyperkalaemia #heartfailure #RAASi
🔗 doi.org/10.1111/joim.70087
#CKD #Hyperkalaemia #heartfailure #RAASi
【K吸着剤でHF例死亡リスクはSPSに比べ高？商業DB/ESC HF】Sep.26
TriNetXデータベース、高K血症合併HF例。PSマッチ可能だったK吸着剤使用例とSPS使用例比較——
・パチロマーでSPSに比べ、「HF入院」と「CV入院」HRは有意低
値も、「死亡」が1.10の有意高値。
・ロケルマはSPSに比べ「死亡」「HF入院」「CV入院」ともHRは有
意に高。
抄録🔗 x.gd/4z45Q [PDF全文Free]
TriNetXデータベース、高K血症合併HF例。PSマッチ可能だったK吸着剤使用例とSPS使用例比較——
・パチロマーでSPSに比べ、「HF入院」と「CV入院」HRは有意低
値も、「死亡」が1.10の有意高値。
・ロケルマはSPSに比べ「死亡」「HF入院」「CV入院」ともHRは有
意に高。
抄録🔗 x.gd/4z45Q [PDF全文Free]
September 28, 2026 at 11:01 PM
【K吸着剤でHF例死亡リスクはSPSに比べ高？商業DB/ESC HF】Sep.26
TriNetXデータベース、高K血症合併HF例。PSマッチ可能だったK吸着剤使用例とSPS使用例比較——
・パチロマーでSPSに比べ、「HF入院」と「CV入院」HRは有意低
値も、「死亡」が1.10の有意高値。
・ロケルマはSPSに比べ「死亡」「HF入院」「CV入院」ともHRは有
意に高。
抄録🔗 x.gd/4z45Q [PDF全文Free]
TriNetXデータベース、高K血症合併HF例。PSマッチ可能だったK吸着剤使用例とSPS使用例比較——
・パチロマーでSPSに比べ、「HF入院」と「CV入院」HRは有意低
値も、「死亡」が1.10の有意高値。
・ロケルマはSPSに比べ「死亡」「HF入院」「CV入院」ともHRは有
意に高。
抄録🔗 x.gd/4z45Q [PDF全文Free]